Jara-Palomares, Luis http://orcid.org/0000-0002-4125-3376
Solier-Lopez, Aurora
Elias-Hernandez, Teresa
Asensio-Cruz, Maria Isabel
Blasco-Esquivias, Isabel
Sanchez-Lopez, Veronica
de la Borbolla, Maria Rodriguez
Arellano-Orden, Elena
Suarez-Valdivia, Lionel
Marin-Romero, Samira
Marin-Barrera, Lucia
Ruiz-Garcia, Aranzazu
Montero-Romero, Emilio
Navarro-Herrero, Silvia
Lopez-Campos, Jose Luis
Serrano-Gotarredona, Maria Pilar
Praena-Fernandez, Juan Manuel
Sanchez-Diaz, Jose Maria
Otero-Candelera, Remedios
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI15/01085, PI15/01085)
Sociedad Española de Neumología y Cirugía Torácica (140/2013, 140/2013)
NEUMOSUR (5/2013); and the LEO Pharma Research Foundation.
Article History
Received: 26 April 2018
Revised: 27 August 2018
Accepted: 31 August 2018
First Online: 15 October 2018
<!--Emphasis Type='Bold' removed-->Availability of data and materials:
: Data available upon request.
: The study protocol was approved by the Research Ethics Committee of Virgen del Rocio Hospital (NCT03134820) and complied with the regulations expressed in Spanish law 14/2007 regarding Biomedical Research. All patients provided written informed consent before enrolment.
: L.J.-P. reports speaker bureau from Bayer Hispania, Actelion, Rovi, PFIZER, and Menarini and from Leo-Pharma, outside the submitted work; and research funding from Leo-Pharma. T.E.-H. reports honoraria for lectures from MSD; honoraria for advisory board activities from Bayer Healthcare and Sanofi; and fees from Bayer Healthcare, GSK, and Actelion. R.O.-C.: honoraria for lectures from Actelion, Leo-Pharma, Bayer Healthcare, MSD, and Sanofi; honoraria for advisory board activities from Actelion, Bayer Healthcare, MSD, and Sanofi; research funding from Bayer Healthcare and Leo-Pharma; and fees from Actelion, Bayer Healthcare, MSD, and Leo Pharma. The other authors declare no competing interests.
: This work was supported by research grants from the Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica (Instituto de Salud Carlos III, Fondo de Investigación Sanitaria; PI15/01085); Sociedad Española de Neumología y Cirugía Torácica (SEPAR; 140/2013); NEUMOSUR (5/2013); and the LEO Pharma Research Foundation.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).